Therefore, pharmacological antagonism of A2ARs may be an effective way to treat EDS using a specific A2AR antagonist or a non-specific antagonist such as caffeine (Chen et al., 2013; Huang et al., 2005; Rodrigues et al., 2016). This evidence concerns the gene ADORA2A and Ehlers-Danlos syndrome.